Company Intelligence Profile
4basecare Onco Solutions Private Limited
Bengaluru-based precision-oncology genomics company (4baseCare brand), an Indian subsidiary of a foreign parent, offering NGS-based cancer biomarker and gene-panel testing.
CIN: U85100KA2020FTC138091ActiveRoC-Bangalore (Karnataka)Confidence: medium
AI OverviewGenerated from public records
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | 4basecare Onco Solutions Private Limited |
|---|---|
| CIN | U85100KA2020FTC138091 |
| PAN | not obtained |
| Status | Active |
| Listing | No — unlisted private company (subsidiary of a foreign company) |
| Incorporated | 03 September 2020 |
| ROC | RoC-Bangalore (Karnataka) |
| Sector (NIC) | Human health activities — oncology clinics / cancer diagnostics & treatment. CIN activity code U85100 (human health activities); reported as hospital & medical care / oncology testing. [Tofler, TheCompanyCheck] |
| Registered address | c/o Institute of Bioinformatics and Applied Biotechnology (IBAB), Biotech Park, Electronics City Phase 1, Bangalore, Karnataka, India – 560100 [Tofler, TheCompanyCheck] |
| Authorized capital | ₹40.0 lakh [Tofler, TheCompanyCheck] |
| Paid-up capital | ₹35.64 lakh [Tofler, TheCompanyCheck] |
Business Overview
Confirmed- 4Basecare Onco Solutions (brand: 4baseCare) is a precision-oncology company using next-generation sequencing (NGS), genomics and digital-health tools for cancer biomarker testing and therapy selection
- Its genomic panels include Indiegene, marketed as an India-population-specific cancer gene panel for biomarker testing
- Founders Hitesh Goswami and Kshitij Rishi started the 4baseCare brand in 2018
- this Indian legal entity was incorporated in September 2020 as a subsidiary of a foreign parent
- Reported headcount ~156 (Mar 2025). [GenomeWeb, IndianStartupNews, TheCompanyCheck]
Directors
Partial / conflicting| Name | DIN | Role | Appointed |
|---|---|---|---|
| Kshitij Datta Rishi | 06442992 | - | 03 Sep 2020 |
Financials
Partial / conflicting- Standalone (unaudited aggregation from directory sources
- treat as indicative, not primary filings)
- FY2025 (year ended 31 Mar 2025): Operating revenue ≈ ₹3.12 crore, reported down ~74% YoY [TheCompanyCheck]
- Tofler corroborates a ~-74.0% total-revenue decline and a ~-98.9% decline in total assets at Mar 2025 [Tofler]
- FY2024 operating revenue was reported in the ₹1cr–₹100cr band (exact figure behind paywall) [Tofler]
- EBITDA, PAT, net worth and borrowings: not obtained (behind premium paywall)
- The steep revenue and asset drop suggests business/assets may have shifted to a sister entity — unverified
- flag for confirmation
Funding
Partial / conflicting- CAUTION — entity-attribution trap
- Public funding coverage is reported against the "4baseCare" brand/group, NOT confirmed against this specific CIN (U85100KA2020FTC138091)
- the recipient may be a sister/parent entity (e.g., 4Basecare Genomics Pvt Ltd or the foreign parent)
- Brand-level rounds reported: pre-Series A ~$2M (consortium of VCs, via PR Newswire)
- Series A $6M led by Yali Capital (GenomeWeb, 2023-24)
- Series B first close Rs 90 crore (investors incl. Ashish Kacholia, Lashit Sanghvi, Yali Capital)
- Series B second close/top-up Rs 38 crore led by growX Ventures and Infosys, taking Series B to ~Rs 128 crore (~$13.3M) [Entrackr, Jun 2026]
- Tracxn cites cumulative ~$25.9M across ~8 rounds (Tracxn used for round names only). [GenomeWeb, Entrackr, SiliconIndia, PR Newswire]
Charges & Loans
ConfirmedNo charges or secured borrowings are registered against this company's assets.
Competitors
Confirmed- MedGenome (large — market leader, ~45% genomic-testing share)
- Strand Life Sciences (mid — clinical genomics/oncology)
- Karkinos Healthcare (mid — NGS-led oncology network)
- Datar Cancer Genetics (mid — molecular oncology, UK+India labs)
- Mapmygenome (small–mid — consumer/clinical genomics)
- Core Diagnostics (mid — oncology diagnostics). [GenomeWeb, ANI, Nexdigm market report]
Frequently Asked Questions
What does 4basecare Onco Solutions Private Limited do?
Bengaluru-based precision-oncology genomics company (4baseCare brand), an Indian subsidiary of a foreign parent, offering NGS-based cancer biomarker and gene-panel testing.
What is the CIN of 4basecare Onco Solutions Private Limited?
The Corporate Identification Number (CIN) of 4basecare Onco Solutions Private Limited is U85100KA2020FTC138091.
Where is 4basecare Onco Solutions Private Limited registered?
4basecare Onco Solutions Private Limited is registered with RoC-Bangalore (Karnataka). Registered address: c/o Institute of Bioinformatics and Applied Biotechnology (IBAB), Biotech Park, Electronics City Phase 1, Bangalore, Karnataka, India – 560100 [Tofler, TheCompanyCheck]
When was 4basecare Onco Solutions Private Limited incorporated?
4basecare Onco Solutions Private Limited was incorporated on 03 September 2020.
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.